Highlights of some of our recent deals in this sector.

Up to £20m

Advised Velleoats, a Russian company that developed and sells a range of fermented oat-based nutritional products.

£20m- £100m

Advised long-standing client Synova Capital on its significant minority growth investment into Preventx. Read more > Advised the shareholders of Argint International on the disposal of the group to Precision Medicine Group. Read more > Advised Takeda on its investment in, and option to acquire, Adaptate Biotherapeutics, a biotechnology company spun-out of GammaDelta Therapeutics.
Advised on a secondary placing and open offer for Creo Medical Group plc. Read more >

£100m+

Advised Universal Health Services on its acquisition of Cambian Group’s Adult Services Division (£377m). Read more > Advised the management team of a property holding company, backed by a portfolio of investors led by Centerbridge Partners, on the sale of its real estate assets to Medical Properties Trust (US$2bn). Read more >